🇺🇸 FDA
Pipeline program

Placebo

CPO-NBP-2002

Phase 2 small_molecule terminated

Quick answer

Placebo for Breast Cancer is a Phase 2 program (small_molecule) at NovaBridge Biosciences with 1 ClinicalTrials.gov record(s).

Program details

Company
NovaBridge Biosciences
Indication
Breast Cancer
Phase
Phase 2
Modality
small_molecule
Status
terminated

Clinical trials